Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: A randomised, open, parallel study

被引：0

|

作者：

Bolli, GB

Capani, F

Home, PD

Kerr, D

Thomas, R

Torlone, E

Selam, JL

Sola-Gazagnes, A

Vitacolonna, E

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A107 / A108

页数：2

相关论文

共 50 条

[41] A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes
Mathur, R
Harmel, AP
DIABETES, 2003, 52 : A438 - A438
[42] The Phenomenon of Pump Therapy in Reduction Daily Insulin Requirement. The Results of Parallel Study on Multiply Daily Injection vs Continuous Subcutaneous Insulin Infusion
Pankowska, Ewa
Blazik, Marlena
Groele, Lidia
DIABETES, 2011, 60 : A635 - A635
[43] Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial
Koivisto, V.
Cleall, S.
Pontiroli, A. E.
Giugliano, D.
DIABETES OBESITY & METABOLISM, 2011, 13 (12): : 1149 - 1157
[44] Comparison of efficacy between twice-daily premixed insulin and once-daily insulin glargine combined with oral hypoglycemic drugs
Kutoh, E
Wajs, J
DIABETES, 2005, 54 : A494 - A494
[45] Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
Kumar, S.
Jang, H. C.
Demirag, N. G.
Skjoth, T. V.
Endahl, L.
Bode, B.
DIABETIC MEDICINE, 2017, 34 (02) : 180 - 188
[46] Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
Lepore, M
Pampanelli, S
Fanelli, C
Porcellati, F
Bartocci, L
Di Vincenzo, A
Cordoni, C
Costa, E
Brunetti, P
Bolli, GB
DIABETES, 2000, 49 (12) : 2142 - 2148
[47] Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study
Hoogma, Roel P. L. M.
Hoekstra, Joost B.
Michels, Bob P.
Levi, Marcel
DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 : S144 - S147
[48] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification-a randomized phase IV trial: Indian subpopulation analyses
Prasanna Kumar, K. M.
Shah, Sanjiv
Shah, Parag
Cleall, Simon
Chen, Steve
Uppal, Shweta
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (02) : 116 - 123
[49] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial (vol 371, pg 1073, 2008)
Bretzel, R. G.
Nuber, U.
Landgraf, W.
Owens, D. R.
Bradley, C.
Linn, T.
LANCET, 2008, 372 (9640): : 718 - 718
[50] Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure
Berthe, E.
Lireux, B.
Coffin, C.
Goulet-Salmon, B.
Houlbert, D.
Boutreux, S.
Fradin, S.
Reznik, Y.
HORMONE AND METABOLIC RESEARCH, 2007, 39 (03) : 224 - 229

← 1 2 3 4 5 →